Deficiencies of Human Complement Component C4a and C4b and Heterozygosity in Length Variants of RP-C4-CYP21-TNX (Rccx) Modules in Caucasians

The complement component C4 genes located in the major histocompatibility complex (MHC) class III region exhibit an unusually complex pattern of variations in gene number, gene size, and nucleotide polymorphism. Duplication or deletion of a C4 gene always concurs with its neighboring genes serine/threonine nuclear protein kinase RP, steroid 21-hydroxylase (CYP21), and tenascin (TNX), which together form a genetic unit termed the RCCX module. A detailed molecular genetic analysis of C4A and C4B and RCCX modular arrangements was correlated with immunochemical studies of C4A and C4B protein polymorphism in 150 normal Caucasians. The results show that bimodular RCCX has a frequency of 69%, whereas monomodular and trimodular RCCX structures account for 17.0 and 14.0%, respectively. Three quarters of C4 genes harbor the endogenous retrovirus HERV-K(C4). Partial deficiencies of C4A and C4B, primarily due to gene deletions and homoexpression of C4A proteins, have a combined frequency of 31.6%. This is probably the most common variation of gene dosage and gene size in human genomes. The seven RCCX physical variants create a great repertoire of haplotypes and diploid combinations, and a heterozygosity frequency of 69.4%. This phenomenon promotes the exchange of genetic information among RCCX constituents that is important in homogenizing the structural and functional diversities of C4A and C4B proteins. However, such length variants may cause unequal, interchromosomal crossovers leading to MHC-associated diseases. An analyses of the RCCX structures in 22 salt-losing, congenital adrenal hyperplasia patients revealed a significant increase in the monomodular structure with a long C4 gene linked to the pseudogene CYP21A, and bimodular structures with two CYP21A, which are likely generated by recombinations between heterozygous RCCX length variants.

[1]  M. Walport,et al.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. , 1983, British medical journal.

[2]  M. Tassabehji,et al.  Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. , 1994, Nucleic acids research.

[3]  Jerzy K. Kulski,et al.  Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease , 1999, Immunological reviews.

[4]  C. Y. Yu,et al.  Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. , 1994, The Journal of biological chemistry.

[5]  J. E. Barbosa,et al.  Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation , 1990, Clinical and experimental immunology.

[6]  L. Truedsson,et al.  Relationship between protein complotypes and DNA variant haplotypes: complotype-RFLP constellations (CRC). , 1997, Human immunology.

[7]  F. Arnett,et al.  A novel immunoassay for the quantitation of human C4 gene products. , 1990, Complement and inflammation.

[8]  R. Campbell,et al.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.

[9]  P. Schneider,et al.  Reference Typing Report for Complement Component C4 , 1999, Experimental and Clinical Immunogenetics.

[10]  P. Schneider,et al.  Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. , 1995, Experimental and clinical immunogenetics.

[11]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[12]  A. Willis,et al.  The reaction mechanism of the internal thioester in the human complement component C4 , 1996, Nature.

[13]  B. Uring-Lambert,et al.  Component deficiencies. 2. The fourth component. , 1986, Progress in allergy.

[14]  P. Schneider,et al.  Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression. , 1993, The Journal of clinical investigation.

[15]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[16]  R. Porter,et al.  Structure and organization of the C4 genes. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[17]  Porter Rr.  Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. , 1983 .

[18]  P. Demant,et al.  A molecular basis for the two locus model of human complement component C4 , 1982, Nature.

[19]  C. Y. Yu,et al.  An Unequal Crossover between the RCCX Modules of the Human MHC Leading to the Presence of a CYP21B Gene and a Tenascin TNXB/TNXA-RP2 Recombinant between C4A and C4B Genes in a Patient with Juvenile Rheumatoid Arthritis , 1999, Experimental and Clinical Immunogenetics.

[20]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[22]  P. White,et al.  Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F J Ayala,et al.  MHC polymorphism and human origins. , 1993, Scientific American.

[24]  F. Christiansen,et al.  Complement allotyping in SLE: association with C4A null. , 1983, Australian and New Zealand journal of medicine.

[25]  J. Young,et al.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. , 1984, Journal of immunology.

[26]  P. Schneider,et al.  Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and for gene conversion at the C4B locus , 1990, The Journal of experimental medicine.

[27]  R. Porter.  Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. , 1983, Molecular biology & medicine.

[28]  M. Carroll,et al.  Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Yunis,et al.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. New,et al.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Belt,et al.  Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region. , 1985, The EMBO journal.

[32]  C. Y. Yu,et al.  Molecular Genetics of the Human MHC Complement Gene Cluster , 1999, Experimental and Clinical Immunogenetics.

[33]  R. Porter,et al.  A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. , 1984, The EMBO journal.

[34]  C. Alper,et al.  Inherited structural polymorphism of the fourth component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Dupont,et al.  Two HLA-linked loci controlling the fourth component of human complement. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Sim,et al.  Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.

[37]  I. Dunham,et al.  Molecular characterization of the HLA‐linked steroid 21‐hydroxylase B gene from an individual with congenital adrenal hyperplasia. , 1987, The EMBO journal.

[38]  H. Grosse-wilde,et al.  Quantitation of the Human Component C4: Definition of C4 Q0 Alleles and C4A Duplications , 1992, Vox sanguinis.

[39]  H. Colten,et al.  Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. , 1999, Journal of immunology.

[40]  C. Y. Yu,et al.  The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. , 1991, Journal of immunology.